UroGen Pharma Company Information

UroGen Pharma Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: UroGen Pharma Ltd.
  • Ticker: URGN
  • Exchange: NasdaqGM
  • Founded: 2004
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$193.956m
  • Shares outstanding: 23.09m
  • Website: https://www.urogen.com

Number of Employees


  • UroGen Pharma Ltd.
  • 400 Alexander Park
  • Princeton
  • New Jersey
  • 8540
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
URGNNasdaqGM (Nasdaq Global Market)YesOrdinary SharesUSUSDMay 2017
UR8DB (Deutsche Boerse AG)YesOrdinary SharesDEEURMay 2017
0XODLSE (London Stock Exchange)YesOrdinary SharesGBUSDMay 2017

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/23 00:00
End of Day Share Price2023/01/20 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.